{
    "nct_id": "NCT06300463",
    "official_title": "Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases",
    "inclusion_criteria": "* Diagnosis of metastatic colorectal adenocarcinoma with liver metastases\n* Participant must be planning to undergo a surgical resection of their liver metastases.\n* Tumor is non-MSI-H/dMMR\n* Presence of measurable disease\n* Participants must be willing to consent to additional molecular analyses of tumor samples removed during surgery for research purposes\n* Women of childbearing potential (WOCBP), or anyone with a uterus, must not be pregnant or breastfeeding. All participants of childbearing potential must agree to use highly effective contraception during this study\n* Participants may not receive chemotherapy, growth factor support, transfusions, or albumin administration within 14 days of start of study treatment.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Not eligible for surgery\n* Any medical condition such as uncontrolled infection, uncontrolled diabetes mellitus or cardiac disease which, in the opinion of the treating physician, would make this protocol unreasonably hazardous for the patient.\n* Previous allogeneic tissue/organ transplant\n* Previously received PD-1, PD-L1, or CTLA-4 therapy including experimental immunologic agents\n* Participants must not have any contraindications to immune checkpoint inhibitors\n* Participants must not have active autoimmune disease that has required systemic treatment within 2 years prior to registration. Some exceptions are allowed",
    "miscellaneous_criteria": ""
}